Abstract
To improve the bioavailability of oleanolic acid (OA), OA-phospholipid complex (OA-PLC) was prepared and evaluated with solubility, differential scanning calorimetry, x-ray powder diffractometry, IR spectroscopy, dissolution study and pharmacokinetic characteristics in rats. Concentrations of OA after oral administration of OA-PLC and OA aqueous suspension in rats were determined by high-performance liquid chromatography/mass spectrometry /mass spectrometry. Solubility of OA-PLC in water and in n-octanol was effectively enhanced by 300 times and 1.2 times, respectively. Spectra of DSC, xRD and IR showed that OA-PLC was formed. Cmax of rats treated with OA and OA-PLC is 0.47 and 1.18 μg/mL, respectively. AUC0→24h and AUC0→∞ values in rats of group OA-PLC were increased significantly (p < 0.01) by 2.06 and 2.16 times compared with those of group OA, respectively. This study indicates the superiority of OA-PLC over OA, in terms of enhanced water and lipid solubility and improved bioavailability in rats.
Keywords: Fructus forsythiae, anti-nociceptive, Radix ginseng, Biopharmaceutics Classification System, Fructus ligustrilucidi, solid dispersion, drug-phospholipid complex, Caco-2 cell monolayers, bergenin, curcumin
Letters in Drug Design & Discovery
Title:Enhanced Oral Bioavailability of Oleanolic Acid in Rats with Phospholipid Complex
Volume: 9 Issue: 5
Author(s): Feng Cao, Yahan Gao, Zhi Yin, Qineng Ping
Affiliation:
Keywords: Fructus forsythiae, anti-nociceptive, Radix ginseng, Biopharmaceutics Classification System, Fructus ligustrilucidi, solid dispersion, drug-phospholipid complex, Caco-2 cell monolayers, bergenin, curcumin
Abstract: To improve the bioavailability of oleanolic acid (OA), OA-phospholipid complex (OA-PLC) was prepared and evaluated with solubility, differential scanning calorimetry, x-ray powder diffractometry, IR spectroscopy, dissolution study and pharmacokinetic characteristics in rats. Concentrations of OA after oral administration of OA-PLC and OA aqueous suspension in rats were determined by high-performance liquid chromatography/mass spectrometry /mass spectrometry. Solubility of OA-PLC in water and in n-octanol was effectively enhanced by 300 times and 1.2 times, respectively. Spectra of DSC, xRD and IR showed that OA-PLC was formed. Cmax of rats treated with OA and OA-PLC is 0.47 and 1.18 μg/mL, respectively. AUC0→24h and AUC0→∞ values in rats of group OA-PLC were increased significantly (p < 0.01) by 2.06 and 2.16 times compared with those of group OA, respectively. This study indicates the superiority of OA-PLC over OA, in terms of enhanced water and lipid solubility and improved bioavailability in rats.
Export Options
About this article
Cite this article as:
Feng Cao, Yahan Gao, Zhi Yin, Qineng Ping , Enhanced Oral Bioavailability of Oleanolic Acid in Rats with Phospholipid Complex, Letters in Drug Design & Discovery 2012; 9 (5) . https://dx.doi.org/10.2174/157018012800389340
DOI https://dx.doi.org/10.2174/157018012800389340 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Categorization & Recognition of Lung Tumor Using Machine Learning Representations
Current Medical Imaging Chemical Constituents and Biological Activity of Chinese Medicinal Herb ‘Xihuangcao’
Combinatorial Chemistry & High Throughput Screening Nanoparticle Enabled Drug Delivery Across the Blood Brain Barrier: in vivo and in vitro Models, Opportunities and Challenges
Current Pharmaceutical Biotechnology Development of Selective Cyclin-Dependent Kinase 4 Inhibitors for Antineoplastic Therapies
Anti-Cancer Agents in Medicinal Chemistry Recent Applications of Doebner, Doebner-von Miller and Knoevenagel-Doebner Reactions in Organic Syntheses
Current Organic Synthesis Stable-Isotope Labeling for Protein Quantitation by Mass Spectrometry
Current Proteomics Improvised Response in 1,4 Dioxane as Co-solvent During Selective Determination of Cerium (III) in Binary Mixtures by Conductometry
Current Analytical Chemistry Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics Extraction, Structure and Bioactivities of the Polysaccharides from Fructus corni
Recent Patents on Food, Nutrition & Agriculture Boronate-Based Fluorescent Probes as a Prominent Tool for H<sub>2</sub>O<sub>2</sub> Sensing and Recognition
Current Medicinal Chemistry Cytotoxic T Cell Reponses Against Immunoglobulin in Malignant and Normal B Cells: Implications for Tumor Immunity and Autoimmunity
Current Pharmaceutical Design Synthesis and Cytotoxicity Studies of New Morpholino-Functionalised and N-Heteroaryl-Substituted Titanocene Anticancer Drugs
Medicinal Chemistry Rapid Biosynthesis of Gold Nanoparticles Using Aqueous-ethanoic Leaf Extract of Heartleaf Moonseed: Characterization and Effect of pH on its Synthesis
Current Nanomaterials 1'-methylspiro[indoline-3,4'-piperidine] Derivatives: Design, Synthesis, Molecular Docking and Anti-tumor Activity Studies
Letters in Drug Design & Discovery The Next Step in Voice Assessment: High-Speed Digital Endoscopy and Objective Evaluation
Current Bioinformatics Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design Erythropoietin and Oxidative Stress
Current Neurovascular Research Synthesis & Characterization of 2-(substituted-phenyl)acetohydrazide Analogs, 1,3,4-oxadiazoles, and 1,2,4-triazine Ring Systems: A Novel Class of Potential Analgesic and Anti-Inflammatory Agents
Letters in Drug Design & Discovery C60 Fullerene Derivatized Nanoparticles and their Application to Therapeutics
Recent Patents on Nanotechnology Minocycline and Cytoprotection: Shedding New Light on a Shadowy Controversy
Current Drug Delivery